Statistics from Altmetric.com
ABSTRACT FROM: Shilyansky C, Williams LM, Gyurak A, et al. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. Lancet Psychiatry 2016;3:425–35.
What is already known on this topic
Cognitive impairment is a reliable feature of major depressive disorder. Depressed individuals perform more poorly than never-depressed healthy volunteers across a range of neuropsychological tests. Cognitive impairments predict poor response to antidepressant drugs, persist after successful treatment1 and are associated with poor psychosocial functioning.2 Remediation of cognitive function in depression, for example by using cognitive training strategies3 or cognitive-enhancing drugs such as modafinil,4 have been shown to boost recovery from depression. The current study aimed to test whether standard antidepressant treatment improves cognitive function in depression.
Methods of the study
This was a longitudinal, randomised, open-label trial assessing the effects of three antidepressant drugs on cognitive function in depressed individuals. There were three treatment arms (one for each drug) as well as an untreated healthy control group. Cognitive performance in depressed patients was assessed at baseline and following 8 weeks of treatment; testing was completed in the control group at the same intervals. The raters who carried out clinical …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.